Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

NCT00569036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Solid Tumors
Metastases

Interventions

DRUG: BMS-754807

Sponsor

Bristol-Myers Squibb